4 ms·
Unsurprising. The pay sucks, hours are long, and the largest industry to hire postdocs (Biomedical) is going through a fairly severe recession that has impacted
by alephnerd 3y ago
Unsurprising. The pay sucks, hours are long, and the largest industry to hire postdocs (Biomedical) is going through a fairly severe recession that has impacted lab developers in Boston and SF as well.
Edit: My analysis of the second order effect is wrong.
From the article - "Much of the shift can be attributed to employment numbers in the biological and biomedical sciences, which saw a 3% drop in the total number of postdocs from 2021 to 2022 and a 10% drop in the number who were U.S. citizens and permanent residents. It’s not clear from the recent data release what’s driving the trends. But the declines coincide with a boom in hiring at biotech companies. And data from a separate survey released by NSF last year indicated fewer U.S. Ph.D. graduates in the life sciences are pursuing postdocs than ever before, with an increasing number heading to industry"
Basically, it looks like you don't need to have a postdoc anymore to work as a researcher in the Biotech industry now.
That said, PE/VC funding has dried up in Biotech compared to a couple years ago
Paying postdocs private sector hourly salaries will probably resolve the issue, but that effort needs to come from the NSF, NIH, DHHS, and other grantmakers.
- robertlagrant 3y ago> Paying postdocs private sector hourly salaries will probably resolve the issue What's the actual issue, though? Is there something bad that this effect is causing?
- alephnerd 3y agoSalaries are basically limited to $50-70k a year with 50-60 hour workweeks. If you did a PhD in Biochemistry, you could make $100-200k a year plus stock working 40-50 hours a week at most working for Pfizer in Cambridge MA instead of earning around $60k working 50-60 hours as a Postdoc at a regional Boston based program like BU or Northeastern - you have to pay the same amount for rent and groceries, but you earn half as much and work much longer hours. At that point, the only reason to be a postdoc is to get your foot in the door if you went to a less recruited program or are from abroad. For example, in the article - “My personal experience is that Americans were always less willing to put up with conditions that foreigners like myself had to put up with,” says McDowell, who moved from the United Kingdom to the United States for a postdoc in biomedicine.
- robertlagrant 3y agoBut what's the actual problem that fewer postdocs causes?
- alephnerd 3y agoMuch less experimental and fundamental research. Companies aren't going to invest in experimental research in the biotech space as the costs are so high. Most compounds end up getting validated in some way shape or form by researchers, then productionized by the private sector. This has a pipeline effect on development in the industry. For example, mRNA Vaccine research was purely experimental research done by postdocs and junior researchers at UPenn in the 1990s, before being commercialized by BioNtech and Moderna in the mid-2000s.
- el_cujo 3y agoThere really isn't one in my opinion. Academic postdoc positions in many fields are pitched as a stepping stone to professorship, but professor positions are very few so you end up with PHDs continuing the low-pay grind after graduation to prop up academia for a dream that doesn't come true. I think it's good more are recognizing this and just going to industry, maybe eventually this will cause problems and academia can be motivated to fix itself instead of viewing post docs as disposable. Or maybe there's no problem to fix and this is academia just getting correctly recognized as the grind option for people who are actually ok with that
- alephnerd 3y ago> academia can be motivated to fix itself The fundamental issues with postdoc salaries and grantmaking lies with the US Government. It is the grantmakers like the CDC, NIH, CMS, DARPA, etc that essentially set postdoc salaries for grants. And these agencies are completely averse to change. Furthermore, us in industry are NOT going to fund fundamental or experimental research due to relatively low margins.
- etrautmann 3y agoThe professor positions themselves aren't particularly cushy at the end of that road. Some postdocs take a look at the prospects of 60-70 hour weeks, very little time to focus on anything scientific or technical, and huge piles of administrative work, and relatively low pay and choose to industry options not out of a lack of the ability to land a professorship.
- dreamcompiler 3y agoLack of research. Most academic research is done by postdocs through grants from e.g. NSF. NSF and other grantors cap postdoc pay at below living wage in expensive cities like Boston. (The professor and university who hire the postdoc have very little flexibility to pay them more.) Add that it's a temp job with no security and fewer people want to sign up. So a lot of cutting-edge research can't get done.
- robertlagrant 3y agoBut is that because a lot of value can be found in these same people producing in industry at the moment? I wonder if there could be a cycle of sometimes discovery being more valuable, because biotech is fairly commoditised, and a cycle of implementation sometimes being more valuable, because we haven't made the most of discoveries.